New pill shows promise for rare Brain-Related obesity
Disease control
Completed
This study tested an experimental drug called LB54640 in 28 people aged 12 and older with hypothalamic obesity, a condition where brain injury causes rapid weight gain. Participants took either the drug or a placebo daily for 14 weeks, then could continue on the drug for up to a …
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC